| COVID-19 epidemiological studies | Lifetime | 1 | US 1 | 99.93 |
| Pneumonia and Respiratory Infections | Lifetime | 5 | US 3 | 99.92 |
| Influenza Virus Research Studies | Lifetime | 16 | US 8 | 99.86 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 28 | US 7 | 99.84 |
| Bacterial Infections and Vaccines | Lifetime | 11 | US 4 | 99.73 |
| Respiratory viral infections research | Lifetime | 29 | US 17 | 99.82 |
| Vaccine Coverage and Hesitancy | Lifetime | 21 | US 11 | 99.62 |
| COVID-19 Clinical Research Studies | Lifetime | 158 | US 42 | 99.15 |
| Antibiotic Use and Resistance | Lifetime | 47 | US 19 | 99.57 |
| Data-Driven Disease Surveillance | Lifetime | 16 | US 10 | 98.94 |
| Viral Infections and Outbreaks Research | Lifetime | 48 | US 26 | 99.28 |
| Antibiotic Resistance in Bacteria | Lifetime | 198 | US 70 | 99.27 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 166 | US 74 | 99.04 |
| COVID-19 Pandemic Impacts | Lifetime | 54 | US 9 | 98.38 |
| SARS-CoV-2 detection and testing | Lifetime | 101 | US 27 | 97.56 |
| Zoonotic diseases and public health | Lifetime | 90 | US 38 | 98.60 |
| Evolution and Genetic Dynamics | Lifetime | 114 | US 42 | 98.51 |
| Animal Disease Management and Epidemiology | Lifetime | 712 | US 232 | 96.77 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 672 | US 277 | 97.23 |
| Streptococcal Infections and Treatments | Lifetime | 606 | US 274 | 96.94 |
| Bacillus and Francisella bacterial research | Lifetime | 419 | US 214 | 94.07 |
| COVID-19 Impact on Reproduction | Lifetime | 723 | US 284 | 88.45 |
| Mathematical and Theoretical Epidemiology and Ecology Models | Lifetime | 790 | US 162 | 92.71 |
| COVID-19 epidemiological studies | 2021-2025 | 6 | US 2 | 99.57 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 51 | US 21 | 99.67 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 27 | US 13 | 99.11 |
| Viral Infections and Outbreaks Research | 2021-2025 | 48 | US 18 | 96.67 |
| COVID-19 Clinical Research Studies | 2021-2025 | 572 | US 140 | 97.45 |
| Influenza Virus Research Studies | 2021-2025 | 205 | US 84 | 95.09 |
| Antibiotic Use and Resistance | 2021-2025 | 248 | US 54 | 94.71 |
| SARS-CoV-2 detection and testing | 2021-2025 | 371 | US 89 | 93.21 |
| Data-Driven Disease Surveillance | 2021-2025 | 80 | US 33 | 90.17 |
